 Home > Medical News >

Medical Research Articles

CHMP recommends neo-base Revlimid's triple therapy for the treatment of patients with multiple myeloma

 Time of Update: 2020-06-10

stem cell capsule a20 cell line new drug pink new alzheimer's drug 2016 autologous cell therapy

recently, Celgene company (http:// announced that the European EMA human medicine (http:// product (http:// Committee (CHMP) recommended that the company's triple therapy based on Revlimid (
Genfit's elafibranor is recognized by fda for treatment of PBC adult patients

 Time of Update: 2020-06-10

levothyroxine weight gain class 2 metabolism test kit central alpha agonists faslodex side effects

Today, Genfit (http:// announced that its flagship product, (http:// elafibranor, has been awarded a breakthrough therapy by the U.S FDA (http:// for the treatment of primary bile bile bili
Lizhu Medicine "recombination of whole human source anti-OX40 monoclonal antibody injection" clinical trial application accepted by the State Drug Administration

 Time of Update: 2020-06-10

rapid drug screen soliris drug zyrtec drug interactions cyclobenzaprine drug test zetia drug

recently, the Pharmaceutical (http:// announced that its holding affiliated company (http:// Zhuhai Lizhu single anti-biotechnology Co., Ltd declared "recombination of all-human source anti-OX
CHMP recommends approval of Lynparza as a single-drug therapy for adult patients with breast cancer

 Time of Update: 2020-06-10

nexium generic name types dendritic cells system 4 microscopic cancer cells pharmaceutical

, the giant a pharmaceutical (http:// and partner Merck and Co announced in that the European (http:// Authority products for human medicine (http:// http:// Committee (CHMP) has issued a p
FDA approves Praluent to reduce risk of angina

 Time of Update: 2020-06-10

lipid lowering drugs acute ischemic stroke unstable angina pectoris all temperatures controlled ldl

recently, Regeneron Pharmaceuticals and Sanofi announced that The FDA (http:// approved a joint development of the praluent to reduce the risk of heart attack, stroke and heart pain in patients w
Fda grants Therachon company apraglutide treatment for orphan drug for short bowel syndrome

 Time of Update: 2020-06-10

new food label definition drug lithium drug interactions hctz drug pcp drug

short bowel syndrome (SBS) is caused by extensive intestinal removal caused by chronic inflammatory bowel disease (IBD), acute events (such as intestinal infarction), or congenital abnormalities re
State Drug Administration approves Gilead Xia Fanning ® to treat chronic hepatitis C virus infection in China

 Time of Update: 2020-06-10

string gene kit gene gene expression prokaryotes mc4r gene gene activation

chronic hepatitis C is a major public health challenge worldwide In China, nearly 10 million people are infected with hCV, of which about 58% are HCV-type 1 patients recently, Gilead Sciences (NASD
FDA approves Tivattozumai anti-biosimilar herzuma for HER2-positive breast cancer treatment

 Time of Update: 2020-06-10

topamax generic name silvadene generic name potassium positive negative 1 8 breast cancer tagamet generic name

, South Korea's bio pharmaceutical (http:// company (http:// Celltrion and partner Teva announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has approved the zotozoc
European Commission approves Emgality injection stomps for preventive treatment of migraines in adults

 Time of Update: 2020-06-10

emgality work 1 month dating phase 2 metabolism new bharat news 1 2 decoder

, pharmaceutical http:// giant Eli Lilly has received big news on EU regulation the new drug (http:// The European Commission (EC) has approved Emgality injections for the preventive treatmen
European Commission approves split dose scheme for Johnson and Johnson Darzalex

 Time of Update: 2020-06-10

3 types fats types dendritic cells plasma cell neoplasm pde5 inhibitor drugs rapid drug test

, the European Commission (EC) has approved Darzalex's split dose plan, the , a http:// company owned by the u.S pharmaceutical (http:// http:// ) giant, , announced the program will provide
European Commission approves listing of Sanofi/Lexicon's Zynquista

 Time of Update: 2020-06-10

commission herpes 1 2 1 3 dibromopropane 1 4 dibromobenzene 139 blood sugar

recently, the European Commission approved the launch of Sanofi/Lexicon (http:// , with 200 mg per day and 400 mg as an insulin-assisted therapy for patients with type 1 diabetes (BMI 27) that con
European Commission approves Roche Tecentriq joint amatin and chemotherapy for first-line treatment in adult patients with non-small cell lung cancer

 Time of Update: 2020-06-10

primary treatment wastewater 5 4 model cdk 4 6 cell platinum geo group locations

recently, Roche, the swiss pharmaceutical (http:// giant, announced that the European Commission (EC) has approved the PD-L1 tumor immunotherapy tecentriq (atezolizumab) combined with Avastin (ge
Sosei announces that its first drug, HTL0014242, has been developed

 Time of Update: 2020-06-10

mouse human klonopin drug test mice treatment imitrex drug class mold 1 control

Recently, Japan's bio medicine (http:// giant Sosei announced that the first subject stake has taken its drug (http:// HTL0014242, a new type of small molecule compound, this test (http://
Bayer's new gynaecological drug, Visanne, has been approved by Chinese regulators to treat endometriosis

 Time of Update: 2020-06-10

cyclosporine brand name 1 4 dibromobenzene canine liver cancer doxazosin 4 mg ketorolac 10 mg

, Germany's pharmaceutical (http:// giant Bayer announced that , the http:// new drug in the of gynaecology, , was approved by Chinese regulators for the treatment of endometriosis (EMs) Visanne
FDA approves Sanofi sugar-lowering drug Soliqua ® 100/33 expansion

 Time of Update: 2020-06-10

long addition demyelination treatment diet bubble drug abilify drug pink new drug

recently, the U.S Food and Drug (http:// Administration ( FDA (http:// ) approved the expanded use of Sanofi's sugar-lowering drug Soliqua ® 100/33 (insulin glargine and lisine peptide injectio
Sanofi fexinidazole approved by DRC for treatment of sleeping sickness

 Time of Update: 2020-06-10

duhring disease simvastatin drug reiters disease what drug klonopin discount health plans

recently, French Pharmaceutical (http:// giant Sanofi announced that fexinidazole has been approved by the Democratic Republic of the Congo (DRC) to treat the tripanos bruceomaiense human African
Cinda Biorecoa Biorecized Whole Human Source Anti-CD47 Monoclonal Antibody Injection (IBI188) Phase I Clinical Study Completes First Patient Administration

 Time of Update: 2020-06-10

mustang bio news phase changes water 1 4 elastic synthesis phase pd l1 ihc

recently, Cinda Bio announced that its self-developed recombinant whole human source anti-CD47 monoclonal antibody injection (research code: IBI188) Phase I clinical study completed the first patien
FDA approves Novartis Mayzent (siponimod) for treatment of adult patients with recurrent multiple sclerosis

 Time of Update: 2020-06-10

multiple sclerosis books clinical assistant salary autism clinical trials fda approved probiotics sunscreen fda approved

recently, Novartis (http:// announced that the U.S FDA (http:// approved its development of Mayzent (http:// for the treatment of recurrent multiple sclerosis (RMS) adult patients, including a
Aishi Corporation announces China's listing of tyrosine kinase inhibitor LeWeima ®

 Time of Update: 2020-06-10

lansoprazole generic name enalapril generic name skelaxin generic name amoxicillin generic name janus kinase inhibitor

liver cancer is the world's second leading cause of cancer-related death, with statistics for 2012 showing that about 750,000 people died from the disease worldwide in the year, as well as about 780
FDA grants AstraZeneca saracatinib an orphan drug for myocotic pulmonary fibrosis

 Time of Update: 2020-06-10

rare diseases org known father medicine india pharmaceutical diagnose lyme disease handbook pharmaceutical excipients

IPF is a rare lung disease that causes fatal, irreversible, progressive lung scars (fibrosis), which can cause breathing difficulties and prevent the heart, muscles and critical organs from getting

Go to Page

Medical Research Articles

CHMP recommends neo-base Revlimid's triple therapy for the treatment of patients with multiple myeloma

Genfit's elafibranor is recognized by fda for treatment of PBC adult patients

Lizhu Medicine "recombination of whole human source anti-OX40 monoclonal antibody injection" clinical trial application accepted by the State Drug Administration

CHMP recommends approval of Lynparza as a single-drug therapy for adult patients with breast cancer

FDA approves Praluent to reduce risk of angina

Fda grants Therachon company apraglutide treatment for orphan drug for short bowel syndrome

State Drug Administration approves Gilead Xia Fanning ® to treat chronic hepatitis C virus infection in China

FDA approves Tivattozumai anti-biosimilar herzuma for HER2-positive breast cancer treatment

European Commission approves Emgality injection stomps for preventive treatment of migraines in adults

European Commission approves split dose scheme for Johnson and Johnson Darzalex

European Commission approves listing of Sanofi/Lexicon's Zynquista

European Commission approves Roche Tecentriq joint amatin and chemotherapy for first-line treatment in adult patients with non-small cell lung cancer

Sosei announces that its first drug, HTL0014242, has been developed

Bayer's new gynaecological drug, Visanne, has been approved by Chinese regulators to treat endometriosis

FDA approves Sanofi sugar-lowering drug Soliqua ® 100/33 expansion

Sanofi fexinidazole approved by DRC for treatment of sleeping sickness

Cinda Biorecoa Biorecized Whole Human Source Anti-CD47 Monoclonal Antibody Injection (IBI188) Phase I Clinical Study Completes First Patient Administration

FDA approves Novartis Mayzent (siponimod) for treatment of adult patients with recurrent multiple sclerosis

Aishi Corporation announces China's listing of tyrosine kinase inhibitor LeWeima ®

FDA grants AstraZeneca saracatinib an orphan drug for myocotic pulmonary fibrosis